Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session I: Current Developments in Colorectal Cancer
Debate: First-Line Treatment in Left-Sided, RAS/BRAF Wild-Type Metastatic Colorectal Cancer: EGFR Inhibitors vs. VEGF Inhibitors - EGFR
Wednesday, November 16, 2022
10:35 AM – 10:43 AM
Debate Speaker(s)
Namrata (Neena) Vijayvergia, MD, FACP
Fox Chase Cancer Center